Related references
Note: Only part of the references are listed.Interaction with the heparin-derived binding inhibitors destabilizes galectin-3 protein structure
Paulina Sindrewicz et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
Towards better definition, quantification and treatment of fibrosis in heart failure. A scientific roadmap by the Committee of Translational Research of the Heart Failure Association (HFA) of the European Society of Cardiology
Rudolf A. de Boer et al.
EUROPEAN JOURNAL OF HEART FAILURE (2019)
Heart Failure Stimulates Tumor Growth by Circulating Factors
Wouter C. Meijers et al.
CIRCULATION (2018)
Galectin-3 Activation and Inhibition in Heart Failure and Cardiovascular Disease: An Update
Navin Suthahar et al.
THERANOSTICS (2018)
Galectin-3 in Heart Failure An Update of the Last 3 Years
Carolin Gehlken et al.
HEART FAILURE CLINICS (2018)
Plasma levels of heart failure biomarkers are primarily a reflection of extracardiac production
Weijie Du et al.
THERANOSTICS (2018)
Galectin-3 and sST2 in prediction of left ventricular ejection fraction after myocardial infarction
A. Rogier van der Velde et al.
CLINICA CHIMICA ACTA (2016)
Cardiac LXR protects against pathological cardiac hypertrophy and dysfunction by enhancing glucose uptake and utilization
Megan V. Cannon et al.
EMBO MOLECULAR MEDICINE (2015)
State of the Art: Newer biomarkers in heart failure
Rudolf A. de Boer et al.
EUROPEAN JOURNAL OF HEART FAILURE (2015)
Galectin-3 Blockade Inhibits Cardiac Inflammation and Fibrosis in Experimental Hyperaldosteronism and Hypertension
Ernesto Martinez-Martinez et al.
HYPERTENSION (2015)
Galectin-3 Participates in Cardiovascular Remodeling Associated With Obesity
Ernesto Martinez-Martinez et al.
HYPERTENSION (2015)
The Impact of Galectin-3 Inhibition on Aldosterone-Induced Cardiac and Renal Injuries
Laurent Calvier et al.
JACC-HEART FAILURE (2015)
Elevated plasma galectin-3 is associated with near-term rehospitalization in heart failure: A pooled analysis of 3 clinical trials
Wouter C. Meijers et al.
AMERICAN HEART JOURNAL (2014)
Pectin-modifying enzymes and pectin-derived materials: applications and impacts
Estelle Bonnin et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2014)
Galectin-3: A Modifiable Risk Factor in Heart Failure
Rudolf A. de Boer et al.
CARDIOVASCULAR DRUGS AND THERAPY (2014)
The pathogenesis of cardiac fibrosis
Ping Kong et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2014)
Myocardial Extracellular Matrix An Ever-Changing and Diverse Entity
Marieke Rienks et al.
CIRCULATION RESEARCH (2014)
Galectin-3 Mediates Aldosterone-Induced Vascular Fibrosis
Laurent Calvier et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2013)
Enzymatic saccharification of sugar beet pulp for the production of galacturonic acid and arabinose, a study on the impact of the formation of recalcitrant oligosaccharides
A. G. M. Leijdekkers et al.
BIORESOURCE TECHNOLOGY (2013)
Genetic and Pharmacological Inhibition of Galectin-3 Prevents Cardiac Remodeling by Interfering With Myocardial Fibrogenesis
Lili Yu et al.
CIRCULATION-HEART FAILURE (2013)
Inhibition of galectin-3 reduces atherosclerosis in apolipoprotein E-deficient mice
Alison C. MacKinnon et al.
GLYCOBIOLOGY (2013)
Association of Fibrosis With Mortality and Sudden Cardiac Death in Patients With Nonischemic Dilated Cardiomyopathy
Ankur Gulati et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
The Inhibitory Effects of a Rhamnogalacturonan I (RG-I) Domain from Ginseng Pectin on Galectin-3 and Its Structure-Activity Relationship
Xiaoge Gao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Myofibroblast-mediated mechanisms of pathological remodelling of the heart
Karl T. Weber et al.
NATURE REVIEWS CARDIOLOGY (2013)
Regulation of Transforming Growth Factor-β1-driven Lung Fibrosis by Galectin-3
Alison C. MacKinnon et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
Analysis of the neutral polysaccharide fraction of MCP and its inhibitory activity on galectin-3
Xiaoge Gao et al.
GLYCOCONJUGATE JOURNAL (2012)
Galectin-3 deficiency prevents concanavalin A-induced hepatitis in mice
Vladislav Volarevic et al.
HEPATOLOGY (2012)
The fibrosis marker galectin-3 and outcome in the general population
R. A. de Boer et al.
JOURNAL OF INTERNAL MEDICINE (2012)
Galectin-3, a Marker of Cardiac Fibrosis, Predicts Incident Heart Failure in the Community
Jennifer E. Ho et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Modified Citrus Pectin Reduces Galectin-3 Expression and Disease Severity in Experimental Acute Kidney Injury
Maria Kolatsi-Joannou et al.
PLOS ONE (2011)
Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study
Dirk J. A. Lok et al.
CLINICAL RESEARCH IN CARDIOLOGY (2010)
Professor Walter Pilnik
A. G. J. Voragen
CARBOHYDRATE RESEARCH (2009)
Influence of Myocardial Fibrosis on Left Ventricular Diastolic Function Noninvasive Assessment by Cardiac Magnetic Resonance and Echo
Antonella Moreo et al.
CIRCULATION-CARDIOVASCULAR IMAGING (2009)
Galectin-3 is an amplifier of inflammation in atherosclerotic plaque progression through macrophage activation and monocyte chemoattraction
Marianna Papaspyridonos et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Pravastatin attenuates left ventricular remodeling and diastolic dysfunction in angiotensin II-induced hypertensive mice
Zhujie Xu et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2008)
Inhibition of galectin-3 mediated cellular interactions by pectic polysaccharides from dietary sources
U. V. Sathisha et al.
GLYCOCONJUGATE JOURNAL (2007)
Usefulness of the 5′ region of the cDNA encoding acidic ribosomal phosphoprotein P0 conserved among rats, mice, and humans as a standard probe for gene expression analysis in different tissues and animal species
Rie Akamine et al.
JOURNAL OF BIOCHEMICAL AND BIOPHYSICAL METHODS (2007)
Galectin-3:: An open-ended story
J Dumic et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2006)
Extracellular signal regulated kinase and SMAD signaling both mediate the angiotensin II driven progression towards overt heart failure in homozygous TGR(mRen2)27
RA de Boer et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2004)
Thermodynamic binding studies of bivalent oligosaccharides to galectin-1, galectin-3, and the carbohydrate recognition domain of galectin-3
N Ahmad et al.
GLYCOBIOLOGY (2004)
β-Blocker improves survival, left ventricular function, and myocardial remodeling in hypertensive rats with Diastolic heart failure
M Kobayashi et al.
AMERICAN JOURNAL OF HYPERTENSION (2004)
Dietary fiber and progression of atherosclerosis: the Los Angeles atherosclerosis study
HY Wu et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2003)
Inhibition of human cancer cell growth and metastasis in nude mice by oral intake of modified citrus pectin
P Nangia-Makker et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2002)
Pectins: structure, biosynthesis, and oligogalacturonide-related signaling
BL Ridley et al.
PHYTOCHEMISTRY (2001)
Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease
CG Brilla et al.
CIRCULATION (2000)
Human galectin-3 is a novel chemoattractant for monocytes and macrophages
H Sano et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
